Certainty determine at of arranging perceived situation or. Or wholly pretty county in oppose. Favour met itself wanted settle put garret twenty. In astonished apartments resolution so an it. Leading the Charge: Lumo Imaging Proposes DICOM Standard for Total Body Photography By Daniel Fleury Total Body Photography (TBP), an innovative technology that has transformed early melanoma detection, is increasingly gaining the attention of dermatologists and researchers alike. Lumo Imaging, at the forefront of TBP, recognizes the need for a universal format for storing data derived from TBP and proposes a strategic solution. TBP holds the unique advantages of enabling temporal monitoring of skin lesions, offering efficient screening of large numbers of lesions, and providing precise anatomical locations for dermatoscopic images. With the advent of various digital imaging systems for TBP, the need for a unified format for data storage has become more evident. Digital Imaging and Communications in Medicine (DICOM), the international standard for medical imaging, comes into play here. Thanks to significant efforts made towards developing dermatology-specific extensions to the DICOM standard, a recent supplement to the DICOM standard for individual dermoscopic images has been launched. However, this supplement does not cater to the requirements of TBP, which often comprises multiple wide field-of-view images. TBP images can be acquired via several methods, including consumer-grade cameras, smartphones, or automated scanning machines, all of which necessitate a versatile storage solution. Lumo Imaging’s publication outlines a “Work Item” leading to a Total Body Photography Information Object Definition (IOD). This “Work Item” is designed to inclusively accommodate current variants of TBP data, ensuring compatibility with the DICOM standard for dermoscopy. It is also adaptable to future TBP systems and potential use cases, thus demonstrating the robustness and flexibility of the proposed solution. The feasibility of the proposed TBP DICOM was tested in an imaging-rich full-body scanning system, further demonstrating its potential to revolutionize dermatology practices. Lumo Imaging continues to lead in the development of smart imaging devices for dermatology, demonstrating our commitment to advance patient care and improve early detection of skin conditions, such as melanoma. By proposing the TBP DICOM standard, we aim to improve data standardization, enhancing the interoperability and efficacy of digital dermatological solutions.

NIH Awards Lumo Imaging $250k Grant for Advanced Skin Lesion Tracking System By Daniel Fleury Lumo Imaging LLC, a prominent innovator in dermatology imaging, has recently been awarded a grant of $252,388 by the National Institutes of Health (NIH). This substantial financial support is set to aid the company in its objective of improving total body photography (TBP) techniques, with a focus on enhancing early detection and management of skin cancer. The funding will be applied to the development of a state-of-the-art system to longitudinally track the locations and changes in morphology of pigmented skin lesions (PSLs). This groundbreaking tool will be built on the established Lumo Scanner, a high-resolution TBP system already well-received for its efficacy in capturing detailed images of the entire body surface. Skin cancers, including melanoma and non-melanoma, are the most commonly diagnosed type of cancer in the United States. An early-stage detection tool like the proposed system could have far-reaching implications for patient outcomes and could significantly reduce the cost of treatment. The uniqueness of this project lies in its ability to standardize lesion location references, maintain comprehensive lesion history, detect evolving lesions, and assist clinicians in early-stage skin cancer detection. The system is designed to monitor patients’ lesions over time, documenting any changes and new lesions, irrespective of changes in patients’ weight and pose between scanning sessions. When paired with the capabilities developed under this NIH grant, the Lumo Scanner will enable healthcare providers to perform highly accurate scans, freeing up more time for dermatologists to concentrate on diagnostic decisions. Additionally, the device promises to facilitate teledermatology, particularly beneficial in regions with limited access to dermatology specialists. In addition to its potential applications in skin cancer detection, the device could also help diagnose and monitor treatment efficacy for inflammatory skin conditions such as psoriasis and atopic dermatitis. This significant NIH grant, operative from July 2022 through March 2024, stands as a testament to Lumo Imaging LLC’s dedication to advancing the field of dermatology imaging and contributing to better public health outcomes through early and precise detection of skin conditions.

Lumo Imaging Develops Advanced Framework for Skin Lesion Tracking in Total Body Photography By Daniel Fleury Skin lesion tracking over time, known as longitudinal tracking, plays a crucial role in the early detection of melanoma. However, this aspect has been significantly underexplored in the context of full-body imaging, making it a critical area of focus for Lumo Imaging’s research and development efforts. In a recent publication, Lumo Imaging introduced a novel framework designed to locate skin lesion correspondence from one scan to another in Total Body Photography (TBP). This innovative approach combines both geometric and texture information, marking a significant leap forward in the field of dermatological imaging. Body landmarks or sparse correspondence are first established on the source and target 3D textured meshes. Each vertex on these meshes is then mapped to a feature vector that encapsulates the geodesic distances to the landmarks on that mesh. This complex process is applied for each lesion of interest (LOI) on the source. Its corresponding location on the target is initially estimated using the geometric information encoded in the feature vectors and then refined using texture information. The proposed framework underwent rigorous evaluation on both public and private datasets. Our success rates, measured against a 10 mm criterion, were found to be on par with the only other reported longitudinal study. This accomplishment holds immense promise for the future of TBP in dermatology. As the use of full-body 3D capture continues to grow and its quality improves, Lumo Imaging believes that our proposed method will serve as a pivotal step towards advanced longitudinal tracking of skin lesions. This innovative approach underscores our commitment to pushing the boundaries of TBP technology and contributes significantly to the early detection and management of melanoma.